Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
Identifying risk factors is crucial for predicting papillary thyroid cancer (PTC) with severe course, which causes a clinical problem. The purpose of this study was to assess whether male sex can be such a predictive factor and to verify whether including it as a predictive factor of high initial ri...
Main Authors: | Aleksandra Gajowiec, Anna Chromik, Kinga Furga, Alicja Skuza, Danuta Gąsior-Perczak, Agnieszka Walczyk, Iwona Pałyga, Tomasz Trybek, Estera Mikina, Monika Szymonek, Klaudia Gadawska-Juszczyk, Artur Kuchareczko, Agnieszka Suligowska, Jarosław Jaskulski, Paweł Orłowski, Magdalena Chrapek, Stanisław Góźdź, Aldona Kowalska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2438 |
Similar Items
-
Does the TT Variant of the rs966423 Polymorphism in <i>DIRC3</i> Affect the Stage and Clinical Course of Papillary Thyroid Cancer?
by: Kinga Hińcza, et al.
Published: (2020-02-01) -
The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence.
by: Aldona Kowalska, et al.
Published: (2016-01-01) -
Incidence of the <i>CHEK2</i> Germline Mutation and Its Impact on Clinicopathological Features, Treatment Responses, and Disease Course in Patients with Papillary Thyroid Carcinoma
by: Danuta Gąsior-Perczak, et al.
Published: (2021-01-01) -
Coexisting Germline <i>CHEK2</i> and Somatic <i>BRAF</i><sup>V600E</sup> Mutations in Papillary Thyroid Cancer and Their Association with Clinicopathological Features and Disease Course
by: Danuta Gąsior-Perczak, et al.
Published: (2019-11-01) -
CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
by: Kinga Hińcza-Nowak, et al.
Published: (2023-06-01)